Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474184 · ClinicalTrials.gov registry record · Phase 1
Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT04474184: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT04474184 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04474184, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This phase I trial investigates the development of a new early detection test to reduce racial disparities in endometrial cancer death rates. DNA samples collected from a tampon may be able to be used to detect endometrial cancer. Studying information from focus groups and vaginal samples of African American and white women may help researchers develop a less invasive and painful test to detect endometrial cancer. The purpose of this trial is to perform a demonstration project of tampon self-collection, assess percentage of samples returned; total and endometrial derived DNA quantity and quality, preliminarily test previously validated DNA methylation markers that may discriminate endometrial cancer from normal endometrium in tampon specimens.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- BEHAVIORAL Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2023-01-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474184
The ClinicalTrials.gov registry entry for NCT04474184 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04474184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474184 about?
NCT04474184 is a clinical study titled "Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates". This phase I trial investigates the development of a new early detection test to reduce racial disparities in endometrial cancer death rates. DNA samples collected from a tampon may be able to be used to detect endometrial cancer. Studying information from focus groups and vaginal samples of African...
What is the current status of trial NCT04474184?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2020-02-01. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT04474184?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Focus Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT04474184?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.